Marc J. Sicklick, M.D., F.A.A.A.A.I., F.A.C.A.A.I.

 

Marc J. Sicklick, M.D.
123 Grove Avenue
Suite 110
Cedarhurst, NY 11516

ph: 516-569-5550

About the FDA's announcement on singulair...

For up to the minute information on the FDA's announcement on singulair, please go to the FDA website at www.fda.gov/medwatch .

 

It is also worthwhile to read the position statement jointly issued by the American College of Allergy, Asthma, and immunology and the American Academy of Allergy, Asthma, and Immunology. Click here to see it : www.aaaai.org

 

The FDA statement was based on  "3 or 4" case reports, and not on a controlled study.  It did not show a "causal relationship" between singulair and the suicides, It is also unclear as to whether or not this reflects an increase in the expected incidence of suicides over what is expected to occur in the general population. 

 

Merck, the producer of singulair, pointed out that none of the 11,000 people enrolled in 40 singulair studies committed suicide.

 

It may take the FDA up to 9 months to offer a definitive recommendation. 

 

Please do not change your asthma medication or your child's asthma medication without first discussing it with me.

Marc J. Sicklick, M.D.
123 Grove Avenue
Suite 110
Cedarhurst, NY 11516

ph: 516-569-5550